A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-05-023796PMID 16954498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.

  2006cited by this paper
• Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

  2006cited by this paper
• Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.

  2005cited by this paper
• Exacerbation of Granuloma Formation in IL-1 Receptor Antagonist-Deficient Mice with Impaired Dendritic Cell Maturation Associated with Th2 Cytokine Production1

  2005cited by this paper
• Multi-dysfunctional pathophysiology in ITP.

  2005cited by this paper
• Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by FcγRIIa and FcγRIIIa polymorphisms

  2004cited by this paper
• IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.

  2003cited by this paper
• Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy.

  2003cited by this paper
• Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

  2003cited by this paper
• Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.

  2003cited by this paper
• Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases

  2003cited by this paper
• Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin.

  2003cited by this paper
• Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

  2003cited by this paper
• Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist.

  2003cited by this paper
• Regulated Expression and Inhibitory Function of FcγRIIb in Human Monocytic Cells*

  2002cited by this paper
• Immunomodulatory action of intravenous immunoglobulin

  2002cited by this paper
• The IL-1 family and inflammatory diseases.

  2002cited by this paper
• Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease.

  2002cited by this paper
• The Epistatic Interrelationships of IL-1, IL-1 Receptor Antagonist, and the Type I IL-1 Receptor1

  2002cited by this paper
• Anti‐D (WinRho SD™) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production

  2002cited by this paper
• IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

  2001cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors.

  2001cited by this paper
• Generation of mature dendritic cells from a CD14+ cell line (XS52) by IL-4, TNF-alpha, IL-1 beta, and agonistic anti-CD40 monoclonal antibody.

  1999cited by this paper
• In vivo modulation of cytokine synthesis by intravenous immunoglobulin

  1999cited by this paper
• Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease.

  1998cited by this paper
• Interleukin-1 receptor antagonist: role in biology.

  1998cited by this paper
• IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils.

  1996cited by this paper
• Selective induction of interleukin‐1 receptor antagonist and interleukin‐8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

  1995cited by this paper
• IgG Induction of IL‐1 Receptor Antagonist Production by Human Monocytes

  1994cited by this paper
• Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.

  1994cited by this paper
• Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages.

  1992cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper

• The Establishment of a Novel Murine Model of Immune Thrombocytopenia in Pregnancy and the Impacts of Thrombopoietin Receptor Agonist on Platelet Production

  2024cites this paper
• Efficacy and safety of intravenous high-dose immunoglobulin in treatment of the severe form of Japanese encephalitis

  2022cites this paper
• Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 – A theoretical perspective

  2021cites this paper
• New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases

  2020cites this paper
• Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Fc Receptor-Targeting Biologics

  2020cites this paper
• High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease

  2019cites this paper
• Aucubin Alleviates Seizures Activity in Li-Pilocarpine-Induced Epileptic Mice: Involvement of Inhibition of Neuroinflammation and Regulation of Neurotransmission

  2019cites this paper
• Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.

  2019cites this paper
• Treating murine inflammatory diseases with an anti-erythrocyte antibody

  2019cites this paper
• FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats

  2019cites this paper
• Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies

  2018cites this paper
• Anti-D: A Type of IVIg

  2018cites this paper
• Mechanisms of Action and Immunomodulation by IVIg

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• GM‐CSF and IL‐4 are not involved in IVIG‐mediated amelioration of ITP in mice: a role for IL‐11 cannot be ruled out

  2018influential citation
• Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

  2017cites this paper
• New aspects on the efficacy of high‐dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia

  2017cites this paper
• Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation

  2017cites this paper
• Mechanisms of action of intravenous immunoglobulin in septic encephalopathy

  2017cites this paper
• Intravenous immunoglobulin for the treatment of childhood encephalitis.

  2017cites this paper
• Anti-RBC Antibody Mediated Erythrocyte Phagocytosis and its Therapeutic Role in Immune Thrombocytopenia (ITP)

  2016cites this paper
• Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.

  2016cites this paper
• Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin

  2016cites this paper
• Human immune globulin infusion in the management of multifocal motor neuropathy

  2015cites this paper
• bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody‐mediated immune activation and repression

  2015cites this paper
• CD44 antibody–mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption

  2015cites this paper
• Fc fusion as a platform technology: potential for modulating immunogenicity.

  2015cites this paper
• Role of immunoglobulin in neuronal apoptosis in a neonatal rat model of hypoxic ischemic brain injury

  2014cites this paper
• Type I and type II Fc receptors regulate innate and adaptive immunity

  2014cites this paper
• Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G.

  2014cites this paper
• The impact of microglial activation on blood-brain barrier in brain diseases

  2014cites this paper
• Role of Inflammatory Mediators in the Pathogenesis of Epilepsy

  2014cites this paper
• Targeting B cells and autoantibodies in the therapy of autoimmune diseases

  2014cites this paper
• Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

  2014cites this paper
• Enhanced Anti-Diabetogenic Effect of Intravenous Immune Globulin Modified by Ferrous Ion Exposure

  2014cites this paper
• Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain

  2014cites this paper
• Cellular immune dysfunction in immune thrombocytopenia (ITP)

  2013cites this paper
• Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway

  2013cites this paper
• Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

  2013cites this paper
• Glia and epilepsy: excitability and inflammation.

  2013cites this paper
• Molecular and Cellular Pathways Involved in the Anti-inflammatory Activity of IgG

  2013cites this paper
• Effect of IVIg on human dendritic cell-mediated antigen uptake and presentation: role of lipid accumulation.

  2012cites this paper
• B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo

  2012cites this paper
• IVIg‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1

  2012cites this paper
• Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis

  2012cites this paper
• The role of sialic acid as a modulator of the anti-inflammatory activity of IgG

  2012cites this paper
• Secretory Leukocyte Protease Inhibitor (SLPI) Decreased the Celluler Expression of NF-Kβ and IL-1β on Wound Macrophages of Rattus novergicus Post Tooth Extraction

  2012cites this paper
• [Intravenous immunoglobulin: immunomodulatory key of the immune system].

  2012cites this paper
• Neuroprotection in Sepsis by Complement Inhibition and Immunoglobulin Therapy

  2012cites this paper
• Delayed hemolytic transfusion reaction in children with sickle cell disease

  2011cites this paper
• Impact of differential glycosylation on IgG activity.

  2011cites this paper
• The role of inflammation in epilepsy

  2011cites this paper
• Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders

  2010cites this paper
• Animal models of immune thrombocytopenia (ITP)

  2010cites this paper
• [Immunoglobulins: multiple potential therapeutic proteins for use in autoimmune disorders].

  2010cites this paper
• Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome.

  2010cites this paper
• Running title: Delayed hemolytic reaction in SCD children

  2010cites this paper
• Antibody‐mediated modulation of immune responses

  2010cites this paper
• Mechanisms of action of intravenous immunoglobulins

  2010cites this paper
• Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

  2009cites this paper
• [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].

  2009cites this paper
• Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.

  2009cites this paper
• The pro and anti-inflammatory activities of immunoglobulin G

  2009cites this paper
• New insight into the mechanism of action of IVIg: the role of dendritic cells

  2009cites this paper
• Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies

  2009cites this paper
• Intravenous Immunoglobulins after Liver Transplantation: new insights in mechanisms of action

  2009cites this paper
• Séance plénière Immunoglobulines intraveineuses dans les maladies auto-immunes et inflammatoires : au-delà d'une simple substitution Mechanisms of action of IVIG in autoimmune and inflammatory disorders: Recent developments

  2009cites this paper
• Immunoglobulines intraveineuses dans les maladies auto-immunes et inflammatoires : au-delà d’une simple substitution

  2009cites this paper
• CD200-dependent and nonCD200-dependant pathways of NK cell suppression by human IVIG

  2008cites this paper
• The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?

  2008cites this paper
• Targeting ischemic brain injury with intravenous immunoglobulin

  2008cites this paper
• Role of natural antibodies in immune homeostasis: IVIg perspective.

  2008cites this paper
• Modulation of the cellular immune system by intravenous immunoglobulin.

  2008cites this paper
• Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer

  2008cites this paper
• Intravenous immunoglobulin products: an update on their mechanisms of action

  2008cites this paper
• The fine transformation between the oxidized and reduced forms of interleukin-1 receptor antagonist.

  2008cites this paper
• Anti-inflammatory actions of intravenous immunoglobulin.

  2008cites this paper
• Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti‐red blood cell antibodies in a mouse model of immune thrombocytopenic purpura

  2007cites this paper
• Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.

  2007cites this paper
• Apoptosis: a target for potentiation of UV-induced IL-1Ra synthesis by IVIg.

  2007cites this paper